{"id":30798,"date":"2017-10-01T07:10:54","date_gmt":"2017-10-01T04:10:54","guid":{"rendered":"http:\/\/infois.ro\/?p=30798"},"modified":"2017-10-01T07:12:18","modified_gmt":"2017-10-01T04:12:18","slug":"de-ziua-inimii-compania-antibiotice-partener-stiintific-la-cel-mai-mare-eveniment-international-de-chirurgie-cardiovasculara-al-anului-2017-desfasurat-in-romania","status":"publish","type":"post","link":"http:\/\/infois.ro\/?p=30798","title":{"rendered":"Compania Antibiotice &#8211; partener \u0219tiin\u021bific la cel mai mare eveniment interna\u021bional de chirurgie cardiovascular\u0103 al anului 2017, desf\u0103\u0219urat \u00een Rom\u00e2nia"},"content":{"rendered":"<p><a href=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice1.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-30799\" src=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice1.jpg\" alt=\"\" width=\"364\" height=\"242\" srcset=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice1.jpg 640w, http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice1-300x199.jpg 300w\" sizes=\"(max-width: 364px) 100vw, 364px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Compania Antibiotice a fost partener principal al Congresului Societ\u0103\u021bii Euro-Asian Bridge for Cardiovascular Surgery (EABM) desf\u0103\u0219urat \u00een perioada 21-24 septembrie 2017 la Ia\u0219i.<\/p>\n<p style=\"text-align: justify;\">Congresul a fost organizat \u00een parteneriat cu Universitatea de Medicin\u0103 \u0219i Farmacie \u201eGr. T. Popa\u201d \u0219i Academia Oamenilor de \u0218tiin\u021b\u0103 din Rom\u00e2nia.<\/p>\n<p style=\"text-align: justify;\">Printre ace\u0219tia se num\u0103r\u0103 prof. Sotirios Prapas, cancelarul Societ\u0103\u021bii Euro-Asian Bridge, Guo-Wei He &#8211; Chinese Academy of Medical Sciences, unul dintre pionierii revasculariz\u0103rii miocardice \u0219i a diferitelor metode de protec\u021bie cardiac\u0103, Hirofumi Takemura, Japonia, Randas Vilela Batista, Brazilia un chirurg temerar \u0219i mare inovator \u00een chirurgia cardiovascular\u0103.<\/p>\n<p style=\"text-align: justify;\">Adev\u0103rat maraton \u0219tiin\u021bific, cu 90 de speakeri \u0219i aproape 600 de participan\u021bi din peste 40 de \u021b\u0103ri, congresul Societ\u0103\u021bii Euro-Asian Bridge for Cardiovascular Surgery (EABM 2017) a reprezentat un eveniment cu un impact important pentru imaginea companiei Antibiotice \u00een r\u00e2ndul speciali\u0219tilor prezen\u021bi la acest eveniment.<\/p>\n<p style=\"text-align: justify;\">\u201e<strong>Compania Antibiotice a reu\u0219it s\u0103 se integreze \u00een lumea \u0219tiin\u021bific\u0103 na\u021bional\u0103 \u0219i interna\u021bional\u0103 \u0219i dup\u0103 p\u0103rerea mea asta este una din cheile succesului acesteia. Remarc portofoliul important de medicamente eficiente care combat \u0219i trateaz\u0103 patologia cardiovascular\u0103. Sunt impresionat c\u0103 delega\u021bii din Serbia, Ucraina, SUA, Vietnam \u0219i China au apreciat nivelul foarte \u00eenalt al liniilor de fabrica\u021bie \u0219i al cercet\u0103rilor pe care le realizeaz\u0103 compania Antibiotice Ia\u0219i. Din acest motiv, apreciez c\u0103 Antibiotice nu este doar o companie produc\u0103toare de medicamente cu exporturi \u00een peste 70 de \u021b\u0103ri ale lumii, dar \u0219i o companie care se implic\u0103 \u00een cercetarea \u0219tiin\u021bific\u0103 \u00een dezvoltarea \u0219i diseminarea cuno\u0219tin\u021belor despre tratamentului diferitor patologii\u201d<\/strong>, a declarat Prof. Dr. Grigore Tinic\u0103, pre\u0219edintele Societ\u0103\u021bii Euro Asian Bridge Surgery.<a href=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice4.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-30800 alignright\" src=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice4.jpg\" alt=\"\" width=\"328\" height=\"246\" srcset=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice4.jpg 640w, http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice4-300x225.jpg 300w\" sizes=\"(max-width: 328px) 100vw, 328px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Printre speakerii rom\u00e2ni la acest congres s-a aflat \u0219i prof. dr. Adrian Streinu Cercel, managerul Institutului Na\u021bional de Boli Infec\u021bioase \u201eProf.dr. Matei Bal\u0219\u201d care a apreciat parteneriatul companiei Antibiotice la cel mai important eveniment dedicat chirurgiei cardiovasculare din Rom\u00e2nia.<\/p>\n<p style=\"text-align: justify;\"><strong>\u201ePentru mine compania Antibiotice reprezint\u0103 o m\u00e2ndrie na\u021bional\u0103 \u0219i este un lucru extraordinar c\u0103 o companie de generice cum este Antibiotice Ia\u0219i s\u0103 fie prezent\u0103 la astfel de manifest\u0103ri \u0219tiin\u021bifice interna\u021bionale, cu at\u00e2t mai mult cu c\u00e2t unul din antibioticele pe care aceast\u0103 companie \u00eel produce reprezint\u0103 un antibiotic deosebit de important folosit pentru tratarea infec\u021biilor cu germeni mul\u021bi rezisten\u021bi. Antibiotice nu a f\u0103cut niciodat\u0103 rabat de la calitate, \u00eendepline\u0219te toate elementele de GMP, ceea ce explic\u0103 recunoa\u0219terea interna\u021bional\u0103, de exemplu \u00een Statele Unite are produse care au avizul FDA \u0219i asta spune cam tot\u201d<\/strong>, a precizat Prof. Dr. Adrian Streinu Cercel, managerul Institutului Na\u021bional de Boli Infec\u021bioase \u201eProf.dr. Matei Bal\u0219\u201d.<\/p>\n<p style=\"text-align: justify;\">Anvergura \u0219tiin\u021bific\u0103 a evenimentului, programul multidisciplinar complex \u0219i participarea profesioni\u0219tilor de elit\u0103 din toate col\u021burile lumii arat\u0103 c\u0103 acest congres a fost un succes.<\/p>\n<p style=\"text-align: justify;\"><strong>\u201eApreciez calitatea acestui congres la care am aflat numeroase informa\u021bii legate de specialitatea \u00een care activez. A fost un eveniment a fost binevenit pentru c\u0103 am avut ocazia s\u0103 aflu mai multe despre compania Antibiotice \u0219i despre portofoliu acesteia. Am apreciat mult prezentarea legat\u0103 de recomand\u0103rile speciali\u0219tilor privind pre\u021buirea antibioticelor \u00een vederea prevenirii rezisten\u021bei la antibiotice, un fenomen actual \u00een toat\u0103 lumea\u201d<\/strong>, a precizat dr. Boris Gingic, cardiolog la Spitalul din Nisch -Serbia.<\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-30801\" src=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice2.jpg\" alt=\"\" width=\"378\" height=\"251\" srcset=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice2.jpg 640w, http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice2-300x199.jpg 300w\" sizes=\"(max-width: 378px) 100vw, 378px\" \/><\/a>Implicarea companiei Antibiotice, ca partener \u0219tiin\u021bific a acestui eveniment a fost apreciat\u0103 de c\u0103tre delega\u021biile de profesioni\u0219ti invita\u021bi la congres.<\/p>\n<p style=\"text-align: justify;\">Delega\u021bia din Ucraina a remarcat faptul c\u0103 Antibiotice investe\u0219te \u00een educa\u021bie \u0219i \u00een formarea medicilor.<\/p>\n<p style=\"text-align: justify;\"><strong>\u201eFaptul c\u0103 Antibiotice investe\u0219te \u00een educa\u021bie \u0219i este partener principal la un eveniment medical care reune\u0219te elita profesioni\u0219tilor din domeniul chirurgiei cardiovasculare interna\u021bionale arat\u0103 respectul pentru cunoa\u0219tere \u0219i \u00een\u021belegerea importan\u021bei acestui fenomen \u00een formarea medicilor. Investind \u00een educa\u021bie, compania Antibiotice \u00ee\u0219i asigur\u0103 perspective foarte bune \u00een viitor\u201d,<\/strong> a precizat prof. Igor Mokryk, chirurg cardiovascular la Institutul Inimii din Kiev Ukraina.<\/p>\n<p style=\"text-align: justify;\">O parte dintre speciali\u0219tii care au participat la programul \u0219tiin\u021bific al evenimentului EABM 2017, au vizitat compania Antibiotice.<\/p>\n<p style=\"text-align: justify;\"><strong>\u201eAm vizitat fabrica \u00een toate segmentele ei, aceasta a fost prima vizit\u0103 a unei fabrici de medicamente din Rom\u00e2nia \u0219i nu exist\u0103 nicio diferen\u021b\u0103 fa\u021b\u0103 de fabricile vizitate de mine p\u00e2n\u0103 acum, dimpotriv\u0103 toata echipa noastr\u0103 a constatat c\u0103 Antibiotice se prezint\u0103 la un nivel mult mai \u00eenalt fa\u021b\u0103 de multe fabrici pe care noi le-am vizitat p\u00e2n\u0103 acum. O parte din produsele companiei sunt \u00eenregistrate recent \u0219i \u00een Serbia iar portofoliul de uz cardiologic pe care \u00eel utiliz\u0103m este foarte bun \u0219i avem \u00eencredere \u00een aceste medicamente<\/strong>\u201d, dr. Alexandru Stancovici, cardiolog directorul adjunct la Spitalul Lescovat, Serbia<a href=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice3.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-30802 alignright\" src=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice3.jpg\" alt=\"\" width=\"355\" height=\"236\" srcset=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice3.jpg 640w, http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice3-300x199.jpg 300w\" sizes=\"(max-width: 355px) 100vw, 355px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Pia\u021ba farmaceutic\u0103 este ast\u0103zi o pia\u021b\u0103 global\u0103, iar medicamentele unei companii farmaceutice pot circula peste tot \u00een lume dup\u0103 ob\u021binerea autoriza\u021biei de punere \u00een pia\u021b\u0103 \u00een teritoriile respective. Patologia medical\u0103 este comun\u0103 \u00een diverse teritorii interna\u021bionale \u0219i lucr\u0103rile Congresului EABM 2017 au dovedit c\u0103 \u0219i solu\u021biile terapeutice, \u0219i deci \u0219i medica\u021bia utilizat\u0103 \u00een Europa \u0219i Asia pentru diversele afec\u021biuni cardiovasculare sau \u00een infec\u021bii, sunt similare.<\/p>\n<p style=\"text-align: justify;\"><strong>\u201eCa partener al Congresului Societ\u0103\u021bii Euro-Asian Bridge for Cardiovascular Surgery (EABM 2017), Antibiotice s-a integrat \u00een platforma \u0219tiin\u021bific\u0103 de comunicare ce a oferit medicilor din diverse teritorii \u00een care compania se dezvolt\u0103, precum Vietnam, Serbia, Ukraina, Moldova, Rusia, SUA, Azerbaijan, oportunitatea de a discuta cu speciali\u0219ti asemeni lor din Rom\u00e2nia, care utilizeaz\u0103 deja de mul\u021bi ani medicamentele noastre antiinfec\u021bioase \u0219i de uz cardiovascular. S-a realizat astfel un schimb de informa\u021bii util, care al\u0103turi de vizitele pe fluxurile de fabrica\u021bie din cadrul companiei au creat un transfer de \u00eencredere \u00een eficacitatea, calitatea \u0219i siguran\u021ba medicamentelor marca Antibiotice. Cuvintele participan\u021bilor la EABM 2017 sunt relevante, \u0219i arat\u0103 aprecierea pentru nivelul performant al speciali\u0219tilor din Rom\u00e2nia, \u0219i pentru Antibiotice, companie de medicamente generice interna\u021bional\u0103, cu sediul \u00een Ia\u0219i, cel mai estic punct al Uniunii Europene, devenit pentru c\u00e2teva zile centrul chirurgiei cardiovasculare mondiale\u201d <\/strong>a declarat doamna dr. Mihaela Mo\u0219negu\u021bu, director Medical Antibiotice SA.<a href=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice5.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-30803\" src=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice5.jpg\" alt=\"\" width=\"342\" height=\"256\" srcset=\"http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice5.jpg 640w, http:\/\/infois.ro\/wp-content\/uploads\/2017\/09\/antibiotice5-300x225.jpg 300w\" sizes=\"(max-width: 342px) 100vw, 342px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compania Antibiotice a fost partener principal al Congresului Societ\u0103\u021bii Euro-Asian Bridge for Cardiovascular Surgery (EABM)&#8230; <a class=\"meta-more\" href=\"http:\/\/infois.ro\/?p=30798\">more <span class=\"meta-nav\">&raquo;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":30802,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41,24],"tags":[74,279,9807,40,9614,9808],"aioseo_notices":[],"_links":{"self":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/30798"}],"collection":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30798"}],"version-history":[{"count":2,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/30798\/revisions"}],"predecessor-version":[{"id":30805,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/30798\/revisions\/30805"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/media\/30802"}],"wp:attachment":[{"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30798"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}